Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy
O Gordeeva - Seminars in cancer biology, 2018 - Elsevier
Cancer-testis antigens (CTAs) are considered as unique and promising cancer biomarkers
and targets for cancer therapy. CTAs are multifunctional protein group with specific …
and targets for cancer therapy. CTAs are multifunctional protein group with specific …
Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy
O Gordeeva - Seminars in cancer biology, 2018 - pubmed.ncbi.nlm.nih.gov
Cancer-testis antigens (CTAs) are considered as unique and promising cancer biomarkers
and targets for cancer therapy. CTAs are multifunctional protein group with specific …
and targets for cancer therapy. CTAs are multifunctional protein group with specific …
Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy
O Gordeeva - Seminars in Cancer Biology, 2018 - elibrary.ru
Cancer-testis antigens (CTAs) are considered as unique and promising cancer biomarkers
and targets for cancer therapy. CTAs are multifunctional protein group with specific …
and targets for cancer therapy. CTAs are multifunctional protein group with specific …
[引用][C] Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy
O Gordeeva - Seminars in Cancer Biology, 2018 - cir.nii.ac.jp
Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy.
O Gordeeva - Seminars in Cancer Biology, 2018 - europepmc.org
Cancer-testis antigens (CTAs) are considered as unique and promising cancer biomarkers
and targets for cancer therapy. CTAs are multifunctional protein group with specific …
and targets for cancer therapy. CTAs are multifunctional protein group with specific …